Usefulness of left ventricular peak filling rate measurement by cardiac MR imaging in heart transplant recipients with cardiac allograft vasculopathy

Usefulness of left ventricular peak filling rate measurement by cardiac MR imaging in heart transplant recipients with cardiac allograft vasculopathy

Bibliographic Details
Main Authors:	Kojima Shinya, Hirata Masami, Otsuka Kuniaki, Kubo Yutaka, Mitsuhashi Tetsuya, Hozo Reiko, Hattammaru Miwa, Nakajima Shun, Kikuchi Tomoko, Suwa Kuniaki, Sekikawa Akihiko, Shitakura Kazunobu, Okajima Kiyotaka, Nunoda Shinichi, Machida Haruhiko, Masukawa Ai, Morita Satoru, Suzuki Kazufumi, Ueno Eiko
Format:	Article
Language:	English
Published:	Elsevier 2010-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Cardiac allograft vasculopathy: How can it be predicted?
by: Rita Calé, et al.
Published: (2020-04-01)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
by: Tracey M Ellimuttil, et al.
Published: (2021-11-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
by: Kobashigawa Jon
Published: (2000-12-01)

Cardiac allograft vasculopathy. A disease on the search for therapy
by: Francisco González Vílchez, et al.
Published: (2019-08-01)

Functional Assessment of Long-Term Microvascular Cardiac Allograft Vasculopathy
by: Noemi Bora, et al.
Published: (2023-12-01)

Factors associated with cardiac allograft vasculopathy after heart transplantation
by: Wioletta Szczurek-Wasilewicz, et al.
Published: (2022-10-01)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
by: Nandini Nair
Published: (2022-08-01)

ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CARDIAC ALLOGRAFT VASCULOPATHY DEVELOPMENT
by: V. V. Chestukhin, et al.
Published: (2013-03-01)

Cardiac allograft vasculopathy: Incidence and predictors in a single-center cohort
by: Sofia Picão, et al.
Published: (2020-04-01)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
by: Milena A. Gebska, MD, PhD, et al.
Published: (2020-02-01)

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
by: Moaz A. Kamel, et al.
Published: (2024-03-01)

Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death
by: Allan D Struthers
Published: (2001-12-01)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
by: Pooja Prasad, et al.
Published: (2023-10-01)

PREGNANCY-ASSOCIATED PLASMA PROTEIN A (PAPP-A) IN CARDIAC ALLOGRAFT VASCULOPATHY
by: О. P. Shevchenko, et al.
Published: (2011-06-01)

Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
by: Fernando Bacal, et al.
Published: (2000-11-01)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
by: Ricardo Wang, et al.
Published: (2015-01-01)

Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
by: Michael Nguyen, et al.
Published: (2018-06-01)

Measuring effective orifice area of bileaflet mechanical valves in patients after aortic valve replacement using phase-contrast cine MR imaging
by: Sasaki Akihito, et al.
Published: (2011-02-01)

Screening of cardiac allograft vasculopathy in heart transplant patients with coronary computed tomography angiography
by: Ana Filipa Amador, et al.
Published: (2024-02-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
by: Carlos A Labarrere, et al.
Published: (2014-01-01)

Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.
by: Christian Zanchin, et al.
Published: (2018-01-01)

Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance
by: Masako Yasuyama, et al.
Published: (2012-07-01)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
by: Masaki Hirose, et al.
Published: (2023-01-01)

Case series: A cautionary tale of screening methods to detect severe cardiac allograft vasculopathy.
by: Nicole K Bart, et al.
Published: (2023-06-01)

Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation.
by: De Souza, A, et al.
Published: (2005)

Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics
by: Elisa Serafini, et al.
Published: (2023-09-01)

Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
by: Natasha Aleksova, MD, et al.
Published: (2021-12-01)

Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling
by: Huijuan Zou, et al.
Published: (2021-03-01)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
by: Annika Gocht, et al.
Published: (2018-07-01)

Molecular Mechanisms of Cardiac Amyloidosis
by: Yukihiro Saito, et al.
Published: (2021-12-01)

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study
by: Marta Jiménez-Blanco Bravo, et al.
Published: (2022-04-01)

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts
by: Camila Iansen Irion, et al.
Published: (2020-08-01)

Cardiac resynchronization therapy with a defibrillator in non‐ischemic and ischemic patients for primary and secondary prevention of sudden cardiac death: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2023-10-01)

Prediction of Short-Term Mortality of Cardiac Care Unit Patients Using Image-Transformed ECG Waveforms
by: Terumasa Kondo, et al.
Published: (2023-01-01)

Vasculopathy in dermatomyositis
by: Xu Hui, et al.
Published: (2024-01-01)

Livedoid vasculopathy
by: Thiago Quadrante Freitas, et al.
Published: (2018-08-01)

Livedoid vasculopathy
by: José Roberto Provenza, et al.